Jennifer Allocco

Jennifer Allocco has a diverse work experience in the pharmaceutical industry. Jennifer started in 2005 with Merck as an Executive Multi Specialty Vaccine Account Manager, where they managed business territory and IDN accounts and received the Vice Presidents Award for Top Performer in 2012 and 2015. Jennifer then transitioned to an Oncology Specialty Representative role, launching anti PD 1 for non small cell king cancer and promoting the oncology portfolio. Jennifer also launched the first hematologic malignancy indication for classical Hodgkin Lymphoma. In 2018, they joined AstraZeneca as an Executive Hematology Account Specialist, and then moved on to ADC Therapeutics in 2021 as a Hematology Therapeutic Specialist. Jennifer is currently serving as an Associate Director Regional Accounts.

Jennifer Allocco holds a Master's degree in Education from Wayne State University, which was completed in 1996. Prior to that, they attended Ursuline Academy Dallas for their earlier education, although specific degree or field of study information for that period is not provided. In addition to their formal education, Jennifer has obtained multiple certifications from LinkedIn in areas such as communication skills, professional presence, and effective speaking. The year and month of obtaining these certifications range from August to October 2022.